5930159 (CDM) by state — Price Transparency

CDM · across United States

5930159 — Inf Tezepelumab(tezspire) 210mg/1.91ml##

State-by-state median negotiated rates. Lower bars are cheaper states; the range bar shows the IQR (25th to 75th percentile within each state).

$17,286 National median

$16,102 – $19,218 IQR (p25 – p75)

1 hospitals filing

1 states

View hospital-by-hospital → Raw rate rows →

Estimate your cost

What would you pay?

Plug in your deductible, what you've already spent against it, your OOP-max, and your coinsurance %. We'll math the rest. Math reference: methodology.

This estimate runs on the hospital’s facility charge only. The surgeon’s and anesthesiologist’s fees are billed separately and aren’t in this number — your EOB shows your complete total.

I am… Annual deductible (assumed — typical plan) Already spent this year

Checked your insurer’s portal? Enter your remaining deductible and out-of-pocket max above/below and leave “already spent” at 0.

Out-of-pocket max (assumed — typical plan) Coinsurance % (after deductible)

Loading estimate…

Median negotiated rate, by state

Ranked by typical (median) negotiated price. Hover for state-level IQR.

Median negotiated rate by state for 5930159 (CDM), with interquartile range
State	Median	p25	p75
KS	$17,286	$16,102	$19,218

Sortable, filterable data table. Use the column headers to sort, the filter row to narrow results.
State	Median	p25	p75	Min	Max	Hospitals	Payers	Rates

KS	$17,286	$16,102	$19,218	$11,427	$21,192	1 ⚠ thin data	6	7